These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1658242)

  • 21. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
    Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
    Fulton D; Urtasun R; Forsyth P
    J Neurooncol; 1996 Feb; 27(2):149-55. PubMed ID: 8699237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of the response of recurrent malignant gliomas treated with interferon alpha with tumor interferon alpha gene content.
    Olson JJ; James CD; Lawson D; Hunter S; Tang G; Billingsley J
    Int J Oncol; 2004 Aug; 25(2):419-27. PubMed ID: 15254740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.
    Hercbergs AA; Goyal LK; Suh JH; Lee S; Reddy CA; Cohen BH; Stevens GH; Reddy SK; Peereboom DM; Elson PJ; Gupta MK; Barnett GH
    Anticancer Res; 2003; 23(1B):617-26. PubMed ID: 12680157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
    Schwer AL; Damek DM; Kavanagh BD; Gaspar LE; Lillehei K; Stuhr K; Chen C
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):993-1001. PubMed ID: 17967517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.
    Brandes AA; Ermani M; Turazzi S; Scelzi E; Berti F; Amistà P; Rotilio A; Licata C; Fiorentino MV
    J Clin Oncol; 1999 Feb; 17(2):645-50. PubMed ID: 10080610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
    Friedman HS; Pluda J; Quinn JA; Ewesuedo RB; Long L; Friedman AH; Cokgor I; Colvin OM; Haglund MM; Ashley DM; Rich JN; Sampson J; Pegg AE; Moschel RC; McLendon RE; Provenzale JM; Stewart ES; Tourt-Uhlig S; Garcia-Turner AM; Herndon JE; Bigner DD; Dolan ME
    J Clin Oncol; 2000 Oct; 18(20):3522-8. PubMed ID: 11032594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.
    Quinn JA; Reardon DA; Friedman AH; Rich JN; Sampson JH; Vredenburgh J; Gururangan S; Provenzale JM; Walker A; Schweitzer H; Bigner DD; Tourt-Uhlig S; Herndon JE; Affronti ML; Jackson S; Allen D; Ziegler K; Bohlin C; Lentz C; Friedman HS
    Neuro Oncol; 2004 Apr; 6(2):145-53. PubMed ID: 15134629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma.
    Yung WK; Castellanos AM; Van Tassel P; Moser RP; Marcus SG
    J Neurooncol; 1990 Aug; 9(1):29-34. PubMed ID: 2082958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic beta-interferon therapy for recurrent gliomas: a brief report.
    Mahaley MS; Dropcho EJ; Bertsch L; Tirey T; Gillespie GY
    J Neurosurg; 1989 Nov; 71(5 Pt 1):639-41. PubMed ID: 2809717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.
    Chinot OL; Honore S; Dufour H; Barrie M; Figarella-Branger D; Muracciole X; Braguer D; Martin PM; Grisoli F
    J Clin Oncol; 2001 May; 19(9):2449-55. PubMed ID: 11331324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
    Kinney P; Triozzi P; Young D; Drago J; Behrens B; Wise H; Rinehart JJ
    J Clin Oncol; 1990 May; 8(5):881-5. PubMed ID: 2332772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance.
    Levin VA; Prados MD
    J Clin Oncol; 1992 May; 10(5):766-71. PubMed ID: 1314890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.
    Gerosa MA; Di Stefano E; Olivi A
    Surg Neurol; 1981 Feb; 15(2):128-34. PubMed ID: 6264637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
    Robins HI; Chang SM; Prados MD; Yung WK; Hess K; Schiff D; Greenberg H; Fink K; Nicolas K; Kuhn JG; Cloughesy T; Junck L; Mehta M
    Neuro Oncol; 2002 Apr; 4(2):109-14. PubMed ID: 11916502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
    Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
    Buckner JC; Brown LD; Kugler JW; Cascino TL; Krook JE; Mailliard JA; Kardinal CG; Tschetter LK; O'Fallon JR; Scheithauer BW
    J Neurosurg; 1995 Mar; 82(3):430-5. PubMed ID: 7861221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer.
    McDonald S; Chang AY; Rubin P; Wallenberg J; Kim IS; Sobel S; Smith J; Keng P; Muhs A
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):613-9. PubMed ID: 8226156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
    Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.